xRead - Nasal Obstruction (September 2024) Full Articles

20426984, 2021, 3, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/alr.22741 by Stanford University, Wiley Online Library on [01/07/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

592

International consensus statement on rhinosinusitis

(Continues)

No addition risk of developing ENS symptoms.

improved the subjective olfaction and

endoscopic appearance in patients

asthma compared with ESS.

The clinical efficacies of radical ESS are comparable with

functional radical ESS plus Draf 3 surgery.

undergoing revision sinus surgery, the

performance of BMTR results in improved

disease-specific QoL. EESS significantly

increased minor bleeding rate associated with MT

resection, particularly if the patient was on anticoagulants.

Study Year LOE Study Design Study Groups Clinical Endpoint Conclusions

with CRSwNP and with

In select patients

Postoperative bleeding There was a significantly

Subjective symptom scores (ADSS,

Lund-Mackay) and ENS6Q

Subjective symptoms and endoscopy

endoscopic scores, CT scores

SNOT-22, chronic sinusitis survey, euroQol 5

symptoms scores,

2. Radical ESS (MT resection) 3. Radical ESS + Draf 3

CRS patients undergoing ESS:

CRSwNP patients with asthma:

1. Extensive ESS (EESS), including MT resection 2. ESS with MT preservation

CRSwNP patients undergoing ESS

1. Functional ESS (MT preservation)

CRS patients undergoing primary and revision ESS: 1. MT resection

1. partial MT resection 2. MT preservation

2. MT preservation

Patients undergoing ESS 1. MT resection 2. MT preservation

nonrandomized cohort (n = 177)

nonrandomized cohort (n = 47)

nonrandomized cohort (n = 406)

nonrandomized cohort (n = 456)

Zhang 2020 2019 3 Prospective cohort (n = 81)

Scangas 2040 2017 3 Prospective

Miller 2070 2016 3 Retrospective

Tan 2065 2018 3 Prospective

Chen 2055 2016 3 Prospective

TABLE XII-19 (Continued)